This topic contains a solution. Click here to go to the answer

Author Question: Better educated and higher social status individuals A. are less likely to use opportunities for ... (Read 83 times)

Hungry!

  • Hero Member
  • *****
  • Posts: 1,071
Better educated and higher social status individuals
 
  A. are less likely to use opportunities for participation.
  B. may have feelings of political efficacy and civic duty.
  C. do not need to organize because they have significant financial resources.
  D. are less likely to organize than working-class individuals.

Question 2

Independent internet sites are regulated as much as TV and radio in the U.S.
 
  Indicate whether this statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

rosiehomeworddo

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

B

Answer to Question 2

False




Hungry!

  • Member
  • Posts: 1,071
Reply 2 on: Jul 8, 2018
Excellent


smrtceo

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library